يعرض 1 - 13 نتائج من 13 نتيجة بحث عن '"Glucose fluxes"', وقت الاستعلام: 0.44s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
  6. 6
  7. 7
    Dissertation/ Thesis
  8. 8

    المصدر: British Journal of Nutrition, 118(10), 777-787. Cambridge University Press

    وصف الملف: application/pdf

  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
  13. 13
    Academic Journal

    وصف الملف: application/pdf

    Relation: Wang, Cong; Dai, Jihuan; Yang, Mengliu; Deng, Guangjiang; Xu, Shengnan; Jia, Yanjun; Boden, Guenther; Ma, Zhongmin A.; Yang, Gangyi; Li, Ling (2014). "Silencing of FGF ‐21 expression promotes hepatic gluconeogenesis and glycogenolysis by regulation of the STAT 3– SOCS 3 signal." FEBS Journal 281(9): 2136-2147.; http://hdl.handle.net/2027.42/106851; FEBS Journal; Uno T, He T, Usui I, Kanatani Y, Bukhari A, Fujisaka S, Yamazaki Y, Suzuki H, Iwata M, Ishiki M, et al. ( 2008 ) Long‐term interleukin‐1α treatment inhibits insulin signaling via IL‐6 production and SOCS3 expression in 3T3‐L1 adipocytes. Horm Metab Res 40, 8 – 12.; To AW, Ribe EM, Chuang TT, Schroeder JE & Lovestone S ( 2011 ) The ε3 and ε4 alleles of human APOE differentially affect tau phosphorylation in hyperinsulinemic and pioglitazone‐treated mice. PLoS ONE 6, e16991.; Li L, Miao Z, Liu R, Yang M, Liu H & Yang G ( 2011 ) Liraglutide prevents hypoadiponectinemia‐induced insulin resistance and alterations of gene expression involved in glucose and lipid metabolism. Mol Med 17, 1168 – 1178.; Kanatani Y, Usui I, Ishizuka K, Bukhari A, Fujisaka S, Urakaze M, Haruta T, Kishimoto T, Naka T & Kobayashi M ( 2007 ) Effects of pioglitazone on suppressor of cytokine signaling 3 expression. Diabetes 56, 795 – 803.; Ramadoss P, Unger‐Smith NE, Lam FS & Hollenberg AN ( 2009 ) STAT3 targets the regulatory regions of gluconeogenic genes in vivo. Mol Endocrinol 23, 827 – 837.; Ling L, Gangyi Y, Shaochuan S, Mengliu Y, Hua L & Boden G ( 2012 ) The effects of fibroblast growth factor‐21 knockdown and over‐expression on its signaling pathway and glucose‐lipid metabolism in vitro. Mol Cell Endocrinol 348, 21 – 26.; Inoue H, Ogawa W, Ozaki M, Haga S, Matsumoto M, Furukawa K, Hashimoto N, Kido Y, Mori T, Sakaue H, et al. ( 2004 ) Role of STAT‐3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat Med 10, 168 – 174.; Howard JK, Flier JS, Howard JK & Flier JS ( 2006 ) Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol Metab 17, 365 – 371.; Moller DE ( 2001 ) New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414, 821 – 827.; Breslow JL ( 1996 ) Mouse models of atherosclerosis. Science 272, 685 – 688.; Zhang SH, Reddick RL, Piedrahita JA & Maeda N ( 1992 ) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258, 468 – 471.; Chen Y, Yang G, Li L, Li K & Chen W ( 2009 ) The changes of glucose‐lipid metabolism in ApoE–/– mice with high‐fat induced insulin resistance. Chin J Diabetes 17, 590 – 592.; Utter MF & Keech DB ( 1963 ) Pyruvate carboxylase. I. Nature of the reaction. J Biol Chem 238, 2603 – 2608.; Ballard FJ & Hanson RW ( 1967 ) The citrate cleavage pathway and lipogenesis in rat adipose tissue: replenishment of oxaloacetate. J Lipid Res 8, 73 – 79.; Inoue H, Ogawa W, Asakawa A, Okamoto Y, Nishizawa A, Matsumoto M, Teshigawara K, Matsuki Y, Watanabe E, Hiramatsu R, et al. ( 2006 ) Role of hepatic STAT3 in brain‐insulin action on hepatic glucose production. Cell Metab 8, 3267 – 3275.; Run‐Zhe S, Feng Z, Fang W, De‐Chun F, Xi‐Hua L, Wei‐Hua R, Xiao‐Lin W, Xue Y, Xiao‐Dong L, Lei H, et al. ( 2009 ) Adiponectin deficiency impairs liver regeneration through attenuating STAT3 phosphorylation in mice. Lab Invest 89, 1043 – 1052.; Ueki K, Kondo T, Tseng YH & Kahn CR ( 2004 ) Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc Natl Acad Sci USA 10, 10422 – 10427.; Torisu T, Sato N, Yoshiga D, Kobayashi T, Yoshioka T, Mori H, Iida M & Yoshimura A ( 2007 ) The dual function of hepatic SOCS3 in insulin resistance in vivo. Genes Cells 12, 143 – 154.; Shi H, Cave B, Inouye K, Bjorbaek C & Flier JS ( 2006 ) Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance. Diabetes 55, 699 – 707.; Yang M, Zhang L, Wang C, Liu H, Boden G, Yang G & Li L ( 2012 ) Liraglutide increases FGF‐21 activity and insulin sensitivity in high fat diet and adiponectin knockdown induced insulin resistance. PLoS ONE 7, e48392.; Sun B, Yang G, Yang M, Liu H, Boden G & Li L ( 2012 ) Long‐term high‐fat diet links the regulation of the insulin‐sensitizing fibroblast growth factor‐21 and visfatin. Cytokine 59, 131 – 137.; Muse ED, Lam TK, Scherer PE & Rossetti L ( 2007 ) Hypothalamic resistin induces hepatic insulin resistance. J Clin Invest 117, 1670 – 1678.; Ling L, Gangyi Y, Shaochuan S, Mengliu Y, Hua L & Boden G ( 2009 ) The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor‐α (TNF‐α) in vivo. Cytokine 45, 12 – 19.; Qin S, Ling L, Renzhe L, Mengliu Y, Hua L & Gangyi Y ( 2009 ) Overexpression of visfatin/PBEF/Nampt alters whole‐body insulin sensitivity and lipid profile in rats. Ann Med 41, 311 – 320.; Zhang L, Yang M, Ren H, Hu H, Boden G, Li L & Yang G ( 2013 ) GLP‐1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c‐JNK. Liver Int 33, 794 – 804.; Ramesha CS, Paul R & Ganguly J ( 1980 ) Effect of dietary unsaturated oils on the biosynthesis of cholesterol, and on biliary and fecal excretion of cholesterol and bile acids in rats. J Nutr 110, 2149 – 2158.; Ferre T, Riu E, Bosch F & Valera A ( 1996 ) Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver. FASEB J 10, 1213 – 1218.; Chen WW, Li L, Yang GY, Li K, Qi XY, Zhu W, Tang Y, Liu H & Boden G ( 2007 ) Circulating FGF‐21 levels in normal subjects and in newly diagnosed patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 115, 1 – 4.; Li L, Yang G, Ning H, Yang M, Liu H & Chen W ( 2008 ) Plasma FGF‐21 levels in type 2 diabetic patients with ketosis. Diabetes Res Clin Pract 82, 209 – 213.; Li K, Li L, Yang M, Zong H, Liu H & Yang G ( 2009 ) Effects of rosiglitazone on fasting plasma fibroblast growth factor‐21 levels in patients with type 2 diabetes mellitus. Eur J Endocrinol 161, 391 – 395.; Muise ES, Azzolina B, Kuo DW, El‐Sherbeini M, Tan Y, Yuan X, Mu J, Thompson JR, Berger JP & Wong KK ( 2008 ) Adipose fibroblast growth factor 21 is up‐regulated by peroxisome proliferator‐activated receptor γ and altered metabolic states. Mol Pharmacol 74, 403 – 412.; Zhang X, Yeung DC, Karpisek M, Stejskal D, Zhou ZG, Liu F, Wong RL, Chow WS, Tso AW, Lam KS, et al. ( 2008 ) Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 57, 1246 – 1253.; Fisher MF, Chui PC, Antonellis PJ, Bina HA, Kharitonenkov A, Flier JS & Maratos‐ Flier E ( 2010 ) Obesity is a fibroblast growth factor 21 (FGF21)‐resistant state. Diabetes 59, 2781 – 2789.; Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA, et al. ( 2005 ) FGF‐21 as a novel metabolic regulator. J Clin Invest 115, 1627 – 1635.; Coskun T, Bina HA, Schneider MA, Dunbar JD, Hu CC, Chen Y, Moller DE & Kharitonenkov A ( 2008 ) Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 149, 6018 – 6027.; Xu J, Lloyd DJ, Hale C, Stanislaus S, Chen M, Sivits G, Vonderfecht S, Hecht R, Li YS, Lindberg RA, et al. ( 2009 ) Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet‐induced obese mice. Diabetes 58, 250 – 259.; Kharitonenkov A, Wroblewski VJ, Koester A, Chen YF, Clutinger CK, Tigno XT, Hansen BC, Shanafelt AB & Etgen GJ ( 2007 ) The metabolic state of diabetic monkeys is regulated by fibroblast growth factor‐21. Endocrinology 148, 774 – 781.; Camporez JP, Jornayvaz FR, Petersen MC, Pesta D, Guigni BA, Serr J, Zhang D, Kahn M, Samuel VT, Jurczak MJ, et al. ( 2013 ) Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice. Endocrinology 154, 3099 – 3109.; Gable D, Sanderson SC & Humphries SE ( 2007 ) Genotypes, obesity and type 2 diabetes – can genetic information motivate weight loss? A review. Clin Chem Lab Med 45, 301 – 308.; Hansmann G, Wagner RA, Schellong S, Perez VA & Urashima T ( 2007 ) Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator‐activated receptor‐γ activation. Circulation 115, 1275 – 1284.